Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study

ConclusionsThis study identified clinical, imaging, and pathological factors that were significantly associated with the final pathology risk. In case of positive MRI followed by TB showing GG2, AS could be offered in patients having a PSAD ≤ 0.20, a tumor length ≤ 6 mm and 1–2 positive cores.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research